Following:

Follow us on:

J Anal Res Clin Med. 2019;7(4): 118-121. doi: 10.15171/jarcm.2019.022

Original Article

Effect of allopurinol in the prevention of contrast-induced nephropathy in patients undergoing angioplasty: randomized clinical trial

Haleh Bodagh ¹ , Zahra Esfahani ¹, Naser Aslanabadi ¹, Bita Amiri ¹, Ali Heidari Sarvestani ¹ *

Cited by CrossRef: 1

1- Lloris-Cejalvo J, Fernández de la Rosa R, Fernández-Valle E, Pozo M, Barrios C, Cejalvo-Lapeña D. Evaluation of 18F-FDG PET imaging for monitoring renal ischemia–reperfusion in experimental model. Current Problems in Surgery. 2026;74:101951 [Crossref]

2- Ali N, Bazan N, Mowafy H, Abdelrahim M, Harb H. Trimetazidine and allopurinol for the prevention of Contrast-associated acute kidney injury in elective percutaneous coronary intervention: a randomized controlled trial. Eur J Clin Pharmacol. 2026;82(2) [Crossref]

3- Badreldin H, Mallya Prabhakar P. Evaluating the Role of Allopurinol in Mitigating Contrast-Induced Nephropathy in Percutaneous Coronary Intervention Patients: A Systematic Review and Meta-Analysis. 2024; [Crossref]